Mastocytosis. General concepts, view on patient management, examples of clinical course of the disease

Authors

DOI:

https://doi.org/10.22141/2224-0551.17.2.2022.1502

Keywords:

mastocytosis, cutaneus mastocytosis, systemic mastocytosis

Abstract

Background. Mastocytosis is a disease characterized by the presence of mast cells in various organs. The skin is affected most often. Almost every patient diagnosed with mastocytosis has skin lesions. This disease is characterized by redness, itching, abdominal pain, diarrhea, musculoskeletal pain, hypotension. These features result from the release of the mast cell mediator and its infiltration into the target organs. Materials and methods. This article describes the symptoms and signs of each and systemic mastocytosis, the principles of their diagnosis, based on recently published іnternational recommendations. Results. According to the 2016 World Health Organization classification, mastocytosis can be divided into cutaneous mastocytosis, systemic mastocytosis and mast cell sarcoma. Cutaneous mastocytosis is divided into three subtypes: maculopapular cutaneous mastocytosis, diffuse cutaneous mastocytosis and cutaneous mastocytoma. Permanent telangiectasia of the macular eruptive form is no longer considered a separate unit. Systemic mastocytosis, in turn, is also divided into indolent, smoldering, aggressive and associated with hematological tumors. Conclusions. Cutaneous manifestations of mastocytosis may vary with age. The classification of cutaneous mastocytosis has recently been updated. As a rule, in patients with mastocytosis in childhood the disease occurs as cutaneous mastocytosis and spontaneously regresses during puberty. On the contrary, in adult patients, despite skin lesions, systemic lesions are often observed, and the course of the disease is usually chronic. That is, patients of any age can be affected. The article describes the causes and pathoge­nesis of mastocytosis with an overview of clinical features, approach to diagnosis and therapy depending on age and severity of the di­sease. Clinical cases for visual acquaintance with a clinical picture of various forms of mastocytosis are resulted.

Downloads

Download data is not yet available.

References

Horny HP, Sotlar K, Valent P, Hartmann K. Mastocytosis: a disease of the hematopoietic stem cell. Dtsch Arztebl Int. 2008 Oct;105(40):686-692. doi:10.3238/arztebl.2008.0686.

Bonadonna P. Mastocytosis: mastocytosis and anaphylaxis. In: European Academy of Allergy and Clinical Immunology (EAACI). Global atlas of skin allergy. Zurich, Switzerland: EAACI; 2019. 196 p.

Janssens AS, Heide R, den Hollander JC, Mulder PG, Tank B, Oranje AP. Mast cell distribution in normal adult skin. J Clin Pathol. 2005 Mar;58(3):285-289. doi:10.1136/jcp.2004.017210.

Carter MC, Metcalfe DD, Komarow HD. Mastocytosis. Immunol Allergy Clin North Am. 2014 Feb;34(1):181-196. doi:10.1016/j.iac.2013.09.001.

Goyal T, Kohli S. Darier’s sign. Indian J Pediatr Dermatol. 2018;19(3):277-279. doi:10.4103/ijpd.IJPD_61_18.

Horny HP, Parwaresch MR, Lennert K. Bone marrow findings in systemic mastocytosis. Hum Pathol. 1985 Aug;16(8):808-814. doi:10.1016/s0046-8177(85)80252-5.

Mancini AJ, Krowchuk DP. Pediatric dermatology: a quick reference guide. 3rd ed. Itasca, IL: AAP; 2016. 745 p.

Brazzelli V, Grassi S, Merante S, et al. Narrow-band UVB phototherapy and psoralen-ultraviolet A photochemotherapy in the treatment of cutaneous mastocytosis: a study in 20 patients. Photodermatol Photoimmunol Photomed. 2016 Sep;32(5-6):238-246. doi:10.1111/phpp.12248.

Bergström A, Rollman O, Emtestam L, et al. Cutaneous mastocytosis - update and clinical guidelines. Lakartidningen. 2018 Oct 22;115:FASY. (in Swedish).

Fedotov VP, Sviatenko TV, Pilipenko AA. Clinical case of rare telangiectatic mastocytosis. In: Dermatovenereology at the turn of the third millennium: Proceeding of the republican scientific and practical conference. 2003, June 19; Belarus, Minsk; 2003. 119-122 pp. (in Russian).

Svjatenko TV, Starostina OA. Analysis of the antipruritic effect of the combined use of desloratadine and dimethindemaleate in the treatment of allergic dermatoses. Zdorov'e rebenka. 2021;16(4):46-52. (in Ukrainian).

Published

2022-06-23

How to Cite

Statkevych, O., & Sviatenko, T. (2022). Mastocytosis. General concepts, view on patient management, examples of clinical course of the disease. CHILD`S HEALTH, 17(2), 99–106. https://doi.org/10.22141/2224-0551.17.2.2022.1502

Issue

Section

To Help the Pediatrician